NCT06298058 2026-01-07
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
Shanghai Institute Of Biological Products
Phase 1 Recruiting
Clinical Trials
10 trialsNCT06992713 2025-07-23
A Clinical Study Evaluating H1710 for Injection in Participants With Advanced Solid Tumors
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT04998422 2025-03-13
A Study of HG381 Administered to Patients With Advanced Solid Tumors
HitGen Inc.
Phase 1 Recruiting
NCT05414136 2024-12-24
Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006
Bio-Thera Solutions
Phase 1 Completed
NCT05819684 2024-06-21
A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
NCT04638491 2024-06-10
Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors Patients
Luye Pharma Group Ltd.
Phase 1 Completed
NCT05877664 2024-03-06
Study of ZG0895.HCl in Patients With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1 Recruiting
NCT05073484 2023-10-11
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients
Bio-Thera Solutions
Phase 1 Terminated
NCT05429398 2022-06-23
A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT01832298 2016-12-20
Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor
Haihe Biopharma Co., Ltd.
Phase 1 Completed